Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) Non Operating Income: 2021-2023

Historic Non Operating Income for Immuneering (IMRX) over the last 2 years, with Dec 2023 value amounting to $464,352.

  • Immuneering's Non Operating Income rose 107.97% to $464,352 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.3 million, marking a year-over-year increase of 515.32%. This contributed to the annual value of $1.3 million for FY2023, which is 515.31% up from last year.
  • According to the latest figures from Q4 2023, Immuneering's Non Operating Income is $464,352, which was down 2.36% from $475,595 recorded in Q3 2023.
  • Immuneering's Non Operating Income's 5-year high stood at $475,595 during Q3 2023, with a 5-year trough of -$118,974 in Q4 2021.
  • Over the past 3 years, Immuneering's median Non Operating Income value was $135,514 (recorded in 2022), while the average stood at $142,405.
  • Data for Immuneering's Non Operating Income shows a peak YoY surged of 1,593.82% (in 2022) over the last 5 years.
  • Over the past 3 years, Immuneering's Non Operating Income (Quarterly) stood at -$118,974 in 2021, then surged by 287.67% to $223,278 in 2022, then skyrocketed by 107.97% to $464,352 in 2023.
  • Its Non Operating Income was $464,352 in Q4 2023, compared to $475,595 in Q3 2023 and $150,193 in Q2 2023.